Document Details
Form
Filing Date
Mar 02, 2022
Document Date
Feb 28, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Paggiarino Dario A.
